Croda International Reports Q1 2026 Sales Growth and Maintains Full-Year Guidance
Croda International reported a 1% increase in Q1 2026 sales at constant currency and reiterated its full-year guidance. The Middle East conflict had no material impact on Q1 results, but rising input costs led to targeted price increases. Consumer Care business grew 4%, while Life Sciences and Industrial segments declined.
Topics: Business Line Trends Guidance Reiteration Input Costs Q1 Earnings Regional Performance Sales Growth